Search results for "cancer risk"

Radioembolization Extends Survival in Select Patients with Advanced Liver Cancer, Study Finds

Radioembolization Extends Survival in Select Patients with Advanced Liver Cancer, Study Finds

Hearing a doctor say that “the cancer has invaded the portal vein” can be deeply overwhelming for patients with liver cancer.
When High Blood Sugar Won’t Go Away: The Overlooked Warning Sign of Pancreatic Cancer

When High Blood Sugar Won’t Go Away: The Overlooked Warning Sign of Pancreatic Cancer

Pancreatic cancer is notoriously difficult to detect in its early stages because symptoms typically manifest late in the disease's progression.
'Lives Before Profits': Dongsan Medical Center’s 127-Year Legacy Drives Blueprint for Regional Healthcare Safety Net

'Lives Before Profits': Dongsan Medical Center’s 127-Year Legacy Drives Blueprint for Regional Healthcare Safety Net

“Emergency care and treatment for high-risk mothers and newborns are not profitable. But they are areas someone must...
Mapping Cancer’s Footprint: Specialized PET/CT Scans Pinpoint Metastasis and Recurrence

Mapping Cancer’s Footprint: Specialized PET/CT Scans Pinpoint Metastasis and Recurrence

Following a cancer diagnosis, patients and their families almost invariably ask the same urgent question: “How far has...
From Bludgeon to Scalpel: ASCO 2026 Signals Oncology’s Shift From ‘Strong Chemo’ to ‘Right Chemo’

From Bludgeon to Scalpel: ASCO 2026 Signals Oncology’s Shift From ‘Strong Chemo’ to ‘Right Chemo’

The standard of care in cancer treatment is undergoing a rapid paradigm shift. For decades, the default oncological...
As 'Super El Niño' Threatens Historic UV Surge, Experts Issue Summer Skin Warnings

As 'Super El Niño' Threatens Historic UV Surge, Experts Issue Summer Skin Warnings

The stinging summer sun has returned. While clear skies and bright days can elevate your mood, longer daylight hours...
SCL Healthcare Secures U.S. Patent for Genetic Test Predicting Metabolic Syndrome Risk

SCL Healthcare Secures U.S. Patent for Genetic Test Predicting Metabolic Syndrome Risk

SCL Healthcare has successfully secured a U.S. patent for a novel genetic testing technology designed to predict an...
MSD Bets $510M on High-Quality Data to Fuel Post-Keytruda AI Drug Discovery

MSD Bets $510M on High-Quality Data to Fuel Post-Keytruda AI Drug Discovery

MSD, which has long dominated the global cancer market with its blockbuster immuno-oncology therapy Keytruda, is...
Kyungpook National University Hospital Establishes Precision Medicine Infrastructure for High-Throughput Proteomic Analysis

Kyungpook National University Hospital Establishes Precision Medicine Infrastructure for High-Throughput Proteomic Analysis

Kyungpook National University Hospital is building an advanced research infrastructure capable of profiling thousands...
Prostate Cancer Now Ranks No. 1 Among Men in South Korea, Yet National Screening Still Excludes Critical PSA Test

Prostate Cancer Now Ranks No. 1 Among Men in South Korea, Yet National Screening Still Excludes Critical PSA Test

Prostate cancer has emerged as the most frequently diagnosed cancer among men in South Korea.